INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.885
+0.095 (5.31%)
Jul 10, 2026, 12:53 PM EDT - Market open
INmune Bio Revenue
In the year 2025, INmune Bio had annual revenue of $50.00K with 257.14% growth.
Revenue (ttm)
$50.00K
Revenue Growth
+257.14%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
21
Market Cap
50.11M
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 50.00K | 36.00K | 257.14% |
| Dec 31, 2024 | 14.00K | -141.00K | -90.97% |
| Dec 31, 2023 | 155.00K | -219.00K | -58.56% |
| Dec 31, 2022 | 374.00K | 193.00K | 106.63% |
| Dec 31, 2021 | 181.00K | 170.00K | 1,545.45% |
| Dec 31, 2020 | 11.00K | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Metagenomi Therapeutics | 22.33M |
| Veru Inc. | 16.89M |
| Apollomics | 8.84M |
| Aligos Therapeutics | 4.71M |
| CervoMed | 2.09M |
| Hyperion DeFi | 1.04M |
| ABVC BioPharma | 797.92K |
INMB News
- 1 day ago - INmune Bio to Present Positive Phase 2 Imaging Data for XPro in Early Alzheimer's Disease at AAIC - GlobeNewsWire
- 9 days ago - INmune Bio advances CORDStrom platform patent application in the U.S. - TheFly
- 9 days ago - INmune Bio Advances CORDStrom™ Platform Patent Application in the U.S. Following Favorable International Written Opinion - GlobeNewsWire
- 15 days ago - INmune Bio receives MHRA approval for Ebstrocel pediatric investigation plan - TheFly
- 15 days ago - INmune Bio Inc. Achieves MHRA Approval of PIP for CORDStrom™ - GlobeNewsWire
- 17 days ago - INmune Bio announces MHRA alignment in pre-MAA CORDStrom meeting - TheFly
- 17 days ago - INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for CORDStrom™ in RDEB - GlobeNewsWire
- 24 days ago - INmune Bio Transcript: AGM 2026 - Transcripts